1029802-00-3

Basic information

• Product Name: 1-[1,3-di(tert-butoxycarbonyl)-2-imidazolidinylimino]-4-methylbenzene
• Synonyms: 1-[1,3-di(tert-butoxycarbonyl)-2-imidazolidinylimino]-4-methylbenzene
• CAS NO: 1029802-00-3
• Molecular Weight: 375.468
• Mol File: 1029802-00-3.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 1-[1,3-di(tert-butoxycarbonyl)-2-imidazolidinylimino]-4-methylbenzene(CAS DataBase Reference)
• NIST Chemistry Reference: 1-[1,3-di(tert-butoxycarbonyl)-2-imidazolidinylimino]-4-methylbenzene(1029802-00-3)
• EPA Substance Registry System: 1-[1,3-di(tert-butoxycarbonyl)-2-imidazolidinylimino]-4-methylbenzene(1029802-00-3)

Safety Data

• Hazardous Substances Data: 1029802-00-3(Hazardous Substances Data)

Upstream product

• 106-49-0 p-toluidine 
• 173300-83-9 2-thioxo-imidazolidine-1,3-dicarboxylic acid di-tert-butyl ester 

Downstream Products

• 4869-96-9 1-(2-imidazolidinylimino)-4-methylbenzene hydrochloride 

Relevant articles and documents

GUANIDINE BASED COMPOUNDS

The adrenergic receptors or adrenoceptors are a family of G-protein coupled receptors split into α and β subclasses. The adrenoceptors have important roles in regulating a myriad of physiological conditions and their malfunction has been implicated in the pathophysiology of a number of diseases. Disclosed herein are a series of novel guanidine and 2-aminoimidazoline compounds which are ligands of the alpha2-adrenoceptor (α2-ARs) subclass of adrenergic receptors. The invention also provides for pharmaceutical compositions comprising the novel compounds. The compounds are suitable for use in the manufacture of medicaments for the treatment of α2-ARs associated disorders, such as depression, schizophrenia, glaucoma and analgesia.